PubRank

Anja K Bosserhoff

Author PubWeight™ 61.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003 2.40
2 miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 2009 2.06
3 Efficient transfection method for primary cells. Tissue Eng 2002 1.74
4 Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med 2009 1.59
5 GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009 1.54
6 Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int J Mol Med 2011 1.49
7 Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 2005 1.41
8 Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 2006 1.29
9 Snail-regulated genes in malignant melanoma. Melanoma Res 2005 1.17
10 Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 2003 1.17
11 Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 2006 1.14
12 A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One 2012 1.07
13 Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). Am J Pathol 2011 1.04
14 H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res 2009 1.04
15 Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res 2005 1.04
16 Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res 2007 1.03
17 Functional implication of Netrin expression in malignant melanoma. Cell Oncol 2009 1.02
18 Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of malignant melanoma. J Cell Biochem 2009 0.99
19 Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 2007 0.98
20 Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development. FEBS J 2009 0.96
21 CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis 2013 0.95
22 Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders. PLoS One 2013 0.95
23 Reduced expression of TANGO in colon and hepatocellular carcinomas. Oncol Rep 2007 0.93
24 Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions. J Dermatol Sci 2013 0.93
25 Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol 2012 0.91
26 Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol 2010 0.91
27 Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int 2004 0.91
28 Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 2007 0.91
29 Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch 2014 0.91
30 Functional role of MIA in melanocytes and early development of melanoma. Oncogene 2004 0.90
31 Induction of Raf kinase inhibitor protein contributes to macrophage differentiation. Biochem Biophys Res Commun 2006 0.90
32 Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem Biophys Res Commun 2006 0.89
33 RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 2005 0.89
34 Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci 2013 0.89
35 Expression of integrin alpha10 is induced in malignant melanoma. Cell Oncol 2007 0.88
36 TANGO is a tumor suppressor of malignant melanoma. Int J Cancer 2006 0.88
37 BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells. Lab Invest 2012 0.88
38 miR(acle)s - new players in the regulation of known suspects. Pigment Cell Melanoma Res 2009 0.88
39 The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J 2009 0.86
40 Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther 2010 0.85
41 Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1. Biochem Biophys Res Commun 2006 0.85
42 Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun. Mol Biol Cell 2009 0.84
43 Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma. Exp Mol Pathol 2013 0.84
44 Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008 0.84
45 BAP1 germline mutation in two first grade family members with uveal melanoma. Br J Ophthalmol 2013 0.84
46 Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol 2006 0.83
47 Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling. Mol Cell Biol 2012 0.83
48 Loss of nephronectin promotes tumor progression in malignant melanoma. Cancer Sci 2008 0.83
49 Annexin A5 is involved in migration and invasion of oral carcinoma. Cell Cycle 2009 0.82
50 Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. J Chromatogr A 2010 0.82
51 Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer 2009 0.82
52 Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res 2011 0.81
53 Meeting report from the 2011 International Melanoma Congress, Tampa, Florida. Pigment Cell Melanoma Res 2011 0.81
54 WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis. EMBO Mol Med 2012 0.80
55 Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells. Cancer Cell Int 2005 0.80
56 Fragments of SLIT3 inhibit cellular migration. Int J Mol Med 2012 0.80
57 Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep 2012 0.79
58 Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res 2002 0.79
59 Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma. Int J Oncol 2004 0.78
60 N-cadherin promoter polymorphisms and risk of osteoarthritis. FASEB J 2013 0.77
61 The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1). FEBS J 2013 0.76
62 In vitro behavior of a porous TiO2/perlite composite and its surface modification with fibronectin. Biomaterials 2005 0.75
63 Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations. Pigment Cell Melanoma Res 2014 0.75
64 Correlation of a novel matrix protein with the degree of cartilage degradation. Rheumatol Int 2002 0.75